I hope this announcement just prior to the conference is just a coincidence. If they are counting on this to make a splash at the conference then I suspect we all will be disappointed.
Not saying the collaboration won't work. But it is years off and milestone payments are not overwhelming. Additonally, Medinol is a private company so its difficult to guage progress. Their history includes lots of litigation, especially with Boston Scientific. Anyone know what percent of the stent market they have?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.